You are here: Industry Insights > Oral

News List

Oral Aspirin Does Not Up FIT Test Sensitivity for ID'ing CRC drugs
May 08, 2019
Oral Aspirin Does Not Up FIT Test Sensitivity for ID'ing CRC.
Single-dose vaccine could provide faster protection against cholera europeanpharmaceuticalreview
May 05, 2019
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera…
Application to EMA filed for the approval of oral semaglutide europeanpharmaceuticalreview
April 30, 2019
It has been announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMA) for oral semaglutide.
Oral sirolimus alters the course of DIPNECH syndrome europeanpharmaceuticalreview
April 25, 2019
Sirolimus, which is used to prevent rejection after kidney transplants has been used to treat idiopathic pulmonary neuroendocrine cell hyperplasia…
Largest oral HPV study in England shows lower rates of infection europeanpharmaceuticalreview
April 22, 2019
The study found that lifestyle factors are incredibly important in preventing infection from HR-HPV, with tobacco usage being a risk factor…
New pill can deliver insulin worldpharmanews
February 12, 2019
An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 2 diabetes have to give themselves every day.
C4X Discovery launches drug discovery partnership with LifeArc pharmaceutical-technology
November 29, 2018
C4X Discovery has formed a discovery partnership with British medical research charity LifeArc to collaborate on the development of small molecule drug candidates active against a novel oncology and inflammation target......
LifeArc negotiates exclusive licence deal with Nemysis for oral iron supplement technology cphi-online
July 21, 2017
IHAT, a novel synthetic material, is a commercially viable alternative to ferrous salts for iron supplementation.
Oral insulin could still be a reality, says Novo Nordisk pharmaphorum
June 15, 2017
Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market .
Recro Gainesville Expands Mfg. Capabilities contractpharma
May 26, 2017
Installs new tableting equipment and grows development team

Previous page 1 2 3 4 Next page